Latest period
$1.26B
YoY change
+15.9%
5Y CAGR
+9.5%
Peak year (2025)
$4.28B
Latest annual
$4.28B
Operating Cash Flow history chart for CME Group (CME) from 2000 to 2025
Latest: $4.28B
Operating Cash Flow growth chart for CME Group (CME) from 2000 to 2025
Latest: +15.9%
Operating Cash Flow history table for CME Group (CME) from 2000 to 2025
| 2025 | $4.28B | +15.9% | +$586.60M | ||
| 2024 | $3.69B | +6.9% | +$236.70M | ||
| 2023 | $3.45B | +13.0% | +$397.80M | ||
| 2022 | $3.06B | +27.2% | +$653.60M | ||
| 2021 | $2.40B | -11.5% | −$313.20M | ||
| 2020 | $2.72B | +1.6% | +$42.80M | ||
| 2019 | $2.67B | +9.5% | +$232.00M | ||
| 2018 | $2.44B | +32.6% | +$600.40M | ||
| 2017 | $1.84B | +7.2% | +$124.40M | ||
| 2016 | $1.72B | +13.2% | +$200.70M | ||
| 2015 | $1.52B | +17.3% | +$223.90M | ||
| 2014 | $1.29B | +0.9% | +$10.90M | ||
| 2013 | $1.28B | +5.2% | +$63.70M | ||
| 2012 | $1.22B | -9.6% | −$129.50M | ||
| 2011 | $1.35B | -0.7% | −$10.10M | ||
| 2010 | $1.36B | +25.2% | +$273.30M | ||
| 2009 | $1.08B | -9.5% | −$114.10M | ||
| 2008 | $1.20B | +47.0% | +$382.82M | ||
| 2007 | $814.37M | +72.6% | +$342.68M | ||
| 2006 | $471.70M | +20.5% | +$80.10M | ||
| 2005 | $391.59M | +19.1% | +$62.79M | ||
| 2004 | $328.81M | +72.0% | +$137.66M | ||
| 2003 | $191.15M | +35.4% | +$50.01M | ||
| 2002 | $141.14M | +17.1% | +$20.57M | ||
| 2001 | $120.57M | +265.7% | +$87.60M | ||
| 2000 | $32.97M | — | — |
- 2025$4.28B+15.9%
- 2024$3.69B+6.9%
- 2023$3.45B+13.0%
- 2022$3.06B+27.2%
- 2021$2.40B-11.5%
- 2020$2.72B+1.6%
- 2019$2.67B+9.5%
- 2018$2.44B+32.6%
- 2017$1.84B+7.2%
- 2016$1.72B+13.2%
- 2015$1.52B+17.3%
- 2014$1.29B+0.9%
- 2013$1.28B+5.2%
- 2012$1.22B-9.6%
- 2011$1.35B-0.7%
- 2010$1.36B+25.2%
- 2009$1.08B-9.5%
- 2008$1.20B+47.0%
- 2007$814.37M+72.6%
- 2006$471.70M+20.5%
- 2005$391.59M+19.1%
- 2004$328.81M+72.0%
- 2003$191.15M+35.4%
- 2002$141.14M+17.1%
- 2001$120.57M+265.7%
- 2000$32.97M—
Operating Cash Flow values are taken from CME Group's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at CME Group (CME)
Operating Cash Flow for CME Group (CME): headline value $1.26B · YoY +15.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of CME Group (CME) operating cash flow is $4.28B – grew 15.9% year-over-year.
CME Group operating cash flow compound annual growth for the 2020–2025 (5 years) window is +9.5%, sustaining 4 straight years of year-over-year growth.
2025 marks the peak operating cash flow at $4.28B, with the historical low of $32.97M recorded in 2000.
CME Group Operating Cash Flow by Year
CME Group Operating Cash Flow 2025: $4.28B
2025's operating cash flow for CME Group came in at $4.28B, grew 15.9% from 2024. This figure represents the highest annual value in the available history.
CME Group Operating Cash Flow 2024: $3.69B
CME Group posted operating cash flow of $3.69B in 2024, grew 6.9% from 2023.
CME Group Operating Cash Flow 2023: $3.45B
In 2023, CME Group reported operating cash flow of $3.45B, grew 13.0% from 2022.
CME Group Operating Cash Flow 2022: $3.06B
CME Group operating cash flow in 2022 was $3.06B, grew 27.2% from 2021.
CME Group Operating Cash Flow 2021: $2.40B
CME Group operating cash flow in 2021 was $2.40B.
See more financial history for CME Group (CME).
Sector peers by Operating Cash Flow
Financial Services peers of CME Group (CME), ranked by their latest operating cash flow
| $100.87B | |
| $49.00B | |
| $45.97B | |
| $23.06B | |
| $17.40B | |
| $12.61B | |
| −$19.00B | |
| −$45.15B |
- $100.87B
- $49.00B
- $45.97B
- $23.06B
- $17.40B
- $12.61B
- −$19.00B
- −$45.15B
Frequently asked questions
CME Group (CME) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation